Drug intelligence / Profile preview

Mejoral

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Rectal
01

Overview

Mejoral is an over-the-counter analgesic and antipyretic medication available in several countries under different formulations. The primary active ingredient in most Mejoral products is acetaminophen (also known as paracetamol), which is used to treat mild to moderate pain such as headaches, menstrual cramps, toothaches, backaches, osteoarthritis pain, and aches associated with cold or flu. Some formulations of Mejoral also contain caffeine to enhance analgesic effects or aspirin (acetylsalicylic acid) for its anti-inflammatory properties. In some regions (such as Ecuador), ibuprofen may be present instead of acetaminophen or aspirin[2][3][5]. Acetaminophen works mainly by inhibiting cyclooxygenase enzymes (COX-1 and COX-2) in the central nervous system to reduce pain and fever; it may also involve other pathways such as serotonergic and endocannabinoid systems[8]. Aspirin acts by irreversibly inhibiting cyclooxygenase enzymes involved in prostaglandin synthesis. Caffeine acts as a central nervous system stimulant that can enhance the effect of analgesics.

Brand names
Mejoral
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)ADOR (Adenosine receptors)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on Mejoral.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mejoral.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call